Literature DB >> 1689515

A study of HLA (Bg) on red cells and platelets by immunoblotting with monoclonal antibodies.

C M Giles1, M Botto, M J King.   

Abstract

HLA class I antigens (Bg) on red cells (RBCs) are expressed by some normal donors and by many patients with systemic lupus erythematosus (SLE). To identify the membrane components previously detected by hemagglutination with HLA class I-specific monoclonal antibodies (MoAbs), RBC membrane preparations were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotted with the HLA class I MoAbs. Two components were obtained that reacted with the MoAbs: a heavy chain of 45 kDa and a light chain termed beta2-microglobulin (beta2-M) of 11 kDa. The effect of chloroquine and acid elution in stripping HLA antigens is shown to be due to the removal of beta2-M, as only that component was detected in eluates from reactive RBCs. Neither antibody elution method affected the heavy chain expression assessed by immunoblotting. It is concluded that HLA class I antigens on RBCs are integral membrane components of the type normally found and wisely distributed on many nucleated cells. Platelets, which have stronger HLA class I antigen expression, were also studied, and their membrane preparations yielded heavy chain and beta2-M molecules; the effect of chloroquine treatment was harder to assess than that of acid elution, owing to the sensitivity with which both components are detected in immunoblotting. In eluates obtained from acid treatment only beta2-M is detected.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1689515     DOI: 10.1046/j.1537-2995.1990.30290162897.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  4 in total

1.  Global proteome analysis identifies active immunoproteasome subunits in human platelets.

Authors:  Cordula Klockenbusch; Geraldine M Walsh; Lyda M Brown; Michael D Hoffman; Vladimir Ignatchenko; Thomas Kislinger; Juergen Kast
Journal:  Mol Cell Proteomics       Date:  2014-08-21       Impact factor: 5.911

2.  Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation.

Authors:  Stefan O Ciurea; Peter F Thall; Denái R Milton; Titus H Barnes; Piyanuch Kongtim; Yudith Carmazzi; Asdrúbal A López; Dianne Y Yap; Uday Popat; Gabriela Rondon; Benjamin Lichtiger; Fleur Aung; Vahid Afshar-Kharghan; Qing Ma; Marcelo Fernández-Viña; Richard E Champlin; Kai Cao
Journal:  Biol Blood Marrow Transplant       Date:  2015-05-15       Impact factor: 5.742

3.  Immunoblotting human C4 bound to human erythrocytes in vivo and in vitro.

Authors:  C M Giles; T Robson
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

4.  Anti-D monoclonal antibodies from 23 human and rodent cell lines display diverse IgG Fc-glycosylation profiles that determine their clinical efficacy.

Authors:  Belinda M Kumpel; Radka Saldova; Carolien A M Koeleman; Jodie L Abrahams; Agnes Hipgrave Ederveen; Kathryn L Armour; Natalia I Olovnikova; Gestur Vidarsson; Rick Kapur; Pauline M Rudd; Manfred Wuhrer
Journal:  Sci Rep       Date:  2020-01-30       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.